Myriad Genetics Inc (MYGN.OQ)

MYGN.OQ on NASDAQ Stock Exchange Global Select Market

37.02USD
25 Jul 2014
Price Change (% chg)

$-0.33 (-0.88%)
Prev Close
$37.35
Open
$37.26
Day's High
$37.68
Day's Low
$36.80
Volume
130,872
Avg. Vol
338,613
52-wk High
$42.44
52-wk Low
$20.02

MYGN.OQ

Chart for MYGN.OQ

About

Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The Company is focused on developing and marketing predictive medicine, personalized medicine and prognostic medicine tests. It performs all of its molecular diagnostic testing and analysis in its own reference laboratories. These technologies include the... (more)

Overall

Beta: 0.99
Market Cap (Mil.): $2,794.67
Shares Outstanding (Mil.): 74.82
Dividend: --
Yield (%): --

Financials

  MYGN.OQ Industry Sector
P/E (TTM): 15.68 59.26 36.21
EPS (TTM): 2.38 -- --
ROI: 26.30 5.98 18.26
ROE: 26.91 9.18 19.13
Search Stocks

Myriad's Huttenlocher bets on a weaker Chinese yuan

HONG KONG, June 12 - Betting on a weaker Chinese currency is the best way for investors to protect an equity portfolio as China enters a protracted period of slowing growth, said Carl Huttenlocher, chief investment officer of Myriad Asset Management.

12 Jun 2014

US STOCKS-Wall Street little changed, near record highs

NEW YORK, March 11 - U.S. stocks were little changed on Tuesday as investors found few reasons to push the S&P 500 above its recent record high, as tensions in Ukraine continued.

11 Mar 2014

US STOCKS-Wall Street to open flat as Ukraine tensions eyed

NEW YORK, March 11 - U.S. stocks were set for a flat open on Tuesday after a slight decline in the prior session left the S&P 500 within striking distance of its recent record high and amid investor caution as tensions in Ukraine continued.

11 Mar 2014

Court denies Myriad motion to block rival genetic tests

- Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company.

11 Mar 2014

UPDATE 1-US court denies Myriad motion to block rival genetic tests

March 11 - Myriad Genetics Inc said a U.S. court denied its motion to temporarily stop rival Ambry Genetics Corp from selling products similar to Myriad's gene-based cancer test, the latest setback for the diagnostics company.

11 Mar 2014

US STOCKS-Futures little changed as Ukraine eyed

* Futures: Dow off 8 pts, S&P off 1.25 pt, Nasdaq up 0.25 pt

11 Mar 2014

US court denies Myriad Genetics' motion to block rival

March 11 - Diagnostics company Myriad Genetics Inc said a U.S. court denied a motion that would have stopped rival Ambry Genetics Corp from selling a similar version of Myriad's cancer test.

11 Mar 2014

MARKET PULSE-Google, Time Warner, Myriad Genetics, Cognizant, Radian

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s) U.S. stock index futures were little changed on Wednesday. Dow Jones industrial average futures were down 0.07 percent at 15,328, S&P 500 futures were down 0.17 percent at 1,740.7 and Nasdaq 100 futures were down 0.03 percent at 3,451.

05 Feb 2014

Myriad Genetics raises full-year forecast on Crescendo buy

- Molecular diagnostics company Myriad Genetics Inc said it plans to buy Crescendo Bioscience for $270 million to enter the autoimmune market, and raised its full-year forecast.

04 Feb 2014

Myriad Genetics raises full-year forecast on Crescendo buy

Feb 4 - Molecular diagnostics company Myriad Genetics Inc said it plans to buy Crescendo Bioscience for $270 million to enter the autoimmune market, and raised its full-year forecast.

04 Feb 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Jefferson Research
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks